Hideki Maeda

1.4k total citations
102 papers, 1.1k citations indexed

About

Hideki Maeda is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and Oncology. According to data from OpenAlex, Hideki Maeda has authored 102 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 22 papers in Economics and Econometrics and 19 papers in Oncology. Recurrent topics in Hideki Maeda's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (14 papers) and Statistical Methods in Clinical Trials (7 papers). Hideki Maeda is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (14 papers) and Statistical Methods in Clinical Trials (7 papers). Hideki Maeda collaborates with scholars based in Japan, United States and Germany. Hideki Maeda's co-authors include Goro Kutomi, Mitsuru Mori, Haruo UZAWA, Toshihiko Torigoe, Atsushi Tanabe, Hiroto Ikeda, Kenji Okita, Kaori Takai, Hiroeki Sahara and K Takata and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hideki Maeda

90 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Maeda Japan 17 490 213 133 97 94 102 1.1k
Wen Ye United States 18 394 0.8× 80 0.4× 30 0.2× 123 1.3× 53 0.6× 50 1.2k
Shuhei Takahashi Japan 19 384 0.8× 63 0.3× 38 0.3× 44 0.5× 65 0.7× 73 1.1k
Mikaël Croyal France 25 626 1.3× 264 1.2× 88 0.7× 76 0.8× 70 0.7× 99 1.7k
R. Kannan Mutharasan United States 16 723 1.5× 368 1.7× 18 0.1× 288 3.0× 205 2.2× 49 1.7k
Longhua Liu China 18 375 0.8× 70 0.3× 38 0.3× 32 0.3× 21 0.2× 43 936
Mazen Kurdi Lebanon 23 616 1.3× 133 0.6× 13 0.1× 269 2.8× 50 0.5× 56 1.5k
Fangfang Lu China 21 712 1.5× 152 0.7× 13 0.1× 82 0.8× 75 0.8× 58 1.3k
Karen J. Klamerus United States 17 500 1.0× 142 0.7× 26 0.2× 347 3.6× 382 4.1× 41 1.3k
Chiming Wei United States 18 398 0.8× 49 0.2× 12 0.1× 54 0.6× 63 0.7× 49 1.2k
Johann Karl Germany 14 806 1.6× 138 0.6× 15 0.1× 261 2.7× 91 1.0× 21 1.5k

Countries citing papers authored by Hideki Maeda

Since Specialization
Citations

This map shows the geographic impact of Hideki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Maeda more than expected).

Fields of papers citing papers by Hideki Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Maeda. The network helps show where Hideki Maeda may publish in the future.

Co-authorship network of co-authors of Hideki Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Maeda. A scholar is included among the top collaborators of Hideki Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Maeda. Hideki Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kikawa, Yuichiro, Yukari Uemura, Tetsuhiko Taira, et al.. (2024). A randomized study comparing electronic patient-reported outcome (ePRO) monitoring with routine follow-up during trastuzumab deruxtecan treatment in patients with metastatic breast cancer (PRO-DUCE study).. Journal of Clinical Oncology. 42(16_suppl). 1504–1504. 1 indexed citations
3.
Maeda, Hideki, et al.. (2024). A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in Japan. Patient Preference and Adherence. Volume 18. 1471–1479. 1 indexed citations
4.
5.
Maeda, Hideki, et al.. (2023). Trends in oncology drug lags in Japan from 2001 to 2020: A cross‐sectional study. Clinical and Translational Science. 16(12). 2665–2674. 7 indexed citations
6.
Maeda, Hideki, et al.. (2023). Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients. Biological and Pharmaceutical Bulletin. 46(8). 1105–1111. 2 indexed citations
7.
Maeda, Hideki, et al.. (2023). Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer. In Vivo. 38(1). 500–505. 1 indexed citations
8.
Maeda, Hideki, et al.. (2023). Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan. JAMA Network Open. 6(4). e238875–e238875. 8 indexed citations
9.
Maeda, Hideki, et al.. (2023). Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan. Current Oncology. 30(2). 1776–1783. 1 indexed citations
10.
11.
Kaneda, Yudai, et al.. (2023). Comparing cancer drug approval systems in the United States and Japan. Health Science Reports. 6(5). e1265–e1265. 1 indexed citations
12.
Takahashi, Masato, Tomofumi Osako, Hiroyuki Yasojima, et al.. (2023). Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole. Breast Cancer. 31(1). 53–62. 2 indexed citations
13.
14.
Maeda, Hideki, Daisuke Kami, Yuki Murata, et al.. (2020). TAT‐dextran–mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes. Journal of Cellular and Molecular Medicine. 24(9). 5007–5020. 47 indexed citations
15.
Abe, Daisuke, Hirokazu Doi, Hideki Maeda, et al.. (2020). Characteristics of the BDNF Val66Met polymorphism in competitive swimmers and judo athletes. Nagasaki University's Academic Output SITE (Nagasaki University). 64(1). 23–29. 4 indexed citations
16.
Tanabe, Atsushi, Kaori Takai, Hiroto Ikeda, et al.. (2016). RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. Cancer Letters. 376(1). 34–42. 210 indexed citations
17.
Shima, Hiroaki, Goro Kutomi, Hideki Maeda, et al.. (2014). Risk of node metastasis of sentinel lymph nodes detected in level II/III of the axilla by single-photon emission computed tomography/computed tomography. Experimental and Therapeutic Medicine. 8(5). 1447–1452. 4 indexed citations
18.
Oshima, Hideki, et al.. (2010). DIAGNOSTIC LAPAROSCOPY USEFUL FOR DETECTING A CASE OF PERITONEAL MALIGNANT MESOTHELIOMA. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 71(3). 844–849. 2 indexed citations
19.
Maeda, Hideki, et al.. (1989). HUMAN THIOLTRANSFERASE : ITS PURIFICATION AND PHYSIOLOGICAL ROLE. Journal of Pharmacobio-Dynamics. 12(3). 1 indexed citations
20.
Maeda, Hideki, Ikuo Ikeda, & M. Sugano. (1975). Behavior of the liver key lipogenesis enzymes in rat fed threonine imbalanced diet. Nutrition reports international. 12(2). 61–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Ye Breakdown of academic impact, for papers by Shuhei Takahashi Breakdown of academic impact, for papers by Mikaël Croyal Breakdown of academic impact, for papers by R. Kannan Mutharasan Breakdown of academic impact, for papers by Longhua Liu Breakdown of academic impact, for papers by Mazen Kurdi Breakdown of academic impact, for papers by Fangfang Lu Breakdown of academic impact, for papers by Karen J. Klamerus Breakdown of academic impact, for papers by Chiming Wei Breakdown of academic impact, for papers by Johann Karl
Rankless by CCL
2026